欧洲神经性疼痛市场 – 行业趋势和 2030 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Europe Neuropathic Pain Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲神经性疼痛市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Sep 2023
  • Europe
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买

Europe Neuropathic Pain Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2023 –2030
Diagram Market Size (Base Year)
 USD 1,123.93 million
Diagram Market Size (Forecast Year)
 USD 2,371.40 million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>欧洲神经性疼痛市场，按类型（脊髓刺激 (SCS) 设备、外部周围神经刺激、经皮神经电刺激 (Tens) 设备）、产品类型（可充电和不可充电）、程序（侵入性和非侵入性）、技术（经皮神经电刺激、经颅磁刺激和呼吸电刺激）、方式（固定式和便携式）、购买方式（非处方设备和处方设备）、疼痛类型（周围神经病变、卡压性神经病变、幻肢神经病变、三叉神经痛、带状疱疹后神经痛 (PHN)、创伤后神经病变、足部疼痛、尾骨痛）、适应症（椎管狭窄、化疗引起的周围神经病变、糖尿病神经病变、其他）、最终用户（医院、诊所、家庭医疗保健、门诊手术中心等）、分销渠道（直接招标、第三方分销商等）——行业趋势和 2030 年预测。

 欧洲神经性疼痛市场

欧洲神经性疼痛市场分析和规模

各市场参与者增加研发支出以创造先进产品，预计将推动欧洲神经性疼痛市场的增长。医疗器械的限制限制了产品的使用，预计将成为欧洲神经性疼痛市场增长的制约因素。许多国家的老龄化和老龄人口增加导致神经性疼痛风险增加，这将为欧洲神经性疼痛市场的增长创造机会。由于医疗支出低和供应链中断，新兴国家使用传统疗法预计将成为欧洲神经性疼痛市场增长的挑战。

Data Bridge Market Research 分析称，欧洲神经性疼痛市场在 2022 年为 11.2393 亿美元，预计到 2030 年将达到 23.714 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 9.1%。由于技术的进步，“脊髓刺激 (SCS) 设备”细分市场在欧洲神经性疼痛市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

欧洲神经性疼痛市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入（百万美元）、销量（单位）、定价（美元）

涵盖的领域

类型（脊髓刺激 (SCS) 设备、外部周围神经刺激、经皮神经电刺激 (TENS) 设备）、产品类型（可充电和不可充电）、程序（侵入性和非侵入性）、技术（经皮神经电刺激、经颅磁刺激和呼吸电刺激）、方式（固定式和便携式）、购买方式（非处方设备和处方设备）、疼痛类型（周围神经病变、卡压性神经病变、幻肢神经病变、三叉神经痛、带状疱疹后神经痛 (PHN)、创伤后神经病变、足部疼痛、尾骨痛）、适应症（椎管狭窄、化疗引起的周围神经病变、糖尿病神经病变、其他）、最终用户（医院、诊所、家庭医疗保健、门诊手术中心及其他）、分销渠道（直接招标、第三方分销商及其他）

覆盖国家

德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区

涵盖的市场参与者

NEVRO CORP.（美国）、波士顿科学公司（美国）、雅培（美国）、electroCore, Inc.（美国）、Polar Medical（英国）、B. Braun Melsungen AG（德国）、Omron Healthcare, Inc.（日本）、Cirtec（美国）、美敦力（爱尔兰）、辉瑞公司（美国）、诺华公司（瑞士）、Virpax Pharmaceuticals, Inc.（美国）、安进公司（美国）、Integer Holdings Corporation（美国）和 AVNS（美国）

市场机会
  • 提高患者意识
  • 医疗支出不断上涨
  • 主要市场参与者不断推出战略举措

市场定义

神经性疼痛是由躯体感觉系统（包括外周纤维（Aβ、Aδ 和 C 纤维）和中枢神经元）的病变或疾病引起的，影响 7-10% 的普通人群。神经性疼痛的病因有多种，由于全球人口老龄化、糖尿病发病率增加以及化疗后癌症生存率提高，其发病率可能会增加。

欧洲神经性疼痛市场动态

驱动程序

  • 神经性疼痛患病率不断上升

随着人口老龄化加剧以及糖尿病和癌症等慢性病的日益普遍，患有神经性疼痛的人数正在增加。这一人口趋势推动了对神经性疼痛治疗和药物的需求。

  • 医学研究进展

对神经性疼痛的病因和机制的持续研究促进了新治疗方案和疗法的开发。随着我们对神经性疼痛的了解不断加深，更有效的治疗方法正在被开发出来，为制药和生物技术公司创造了机会。

  • 新药开发

制药公司正在投资开发专门针对神经性疼痛的新药。这些药物旨在提供更好的止痛效果和更少的副作用，从而改善患者的生活质量。

机会

  • 患者意识不断增强

随着人们对神经性疼痛及其对患者生活的影响的认识不断提高，对有效治疗的需求也越来越大。患者在寻求适当的护理和治疗方面也变得更加积极主动。

  • 医疗支出上升

随着全球医疗保健支出不断增加，用于神经性疼痛治疗和疗法的研究、开发和获取的资金也越来越多。

限制/挑战

  • 当前治疗效果有限

现有的许多神经性疼痛药物和疗法只能部分缓解疼痛，而且可能产生副作用。这种有限的疗效可能导致患者不满，并寻求替代疗法。

  • 副作用和安全问题

一些神经性疼痛药物，包括阿片类药物和某些抗抑郁药，会引起嗜睡、头晕和成瘾等副作用。控制这些副作用对患者和医疗保健提供者来说都是一项挑战。

这份欧洲神经性疼痛市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关欧洲神经性疼痛市场的更多信息，请联系 Data Bridge 市场研究部门获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

最新动态

  • 2023 年 1 月，雅培宣布美国食品药品监督管理局 (FDA) 批准其 Proclaim XR 脊髓刺激 (SCS) 系统用于治疗糖尿病疼痛性周围神经病变 (DPN)，这是一种使人衰弱的糖尿病并发症
  •  2022 年 7 月，Vertex Pharmaceuticals Incorporated 宣布美国食品药品监督管理局 (FDA) 公布了 VX-548 在急性和神经性疼痛治疗中的第 2 期积极结果

欧洲神经性疼痛市场范围

欧洲神经性疼痛市场根据类型、产品类型、程序、技术、方式、购买方式、疼痛类型、适应症、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

  • 脊髓刺激 (SCS) 设备
  • 外部周围神经刺激
  • 经皮神经电刺激 (TENS) 设备

产品类型

  • 可充电的
  • 不可充电

程序

  • 侵入性
  • 非侵入性

技术

  • 经皮神经电刺激
  • 经颅磁刺激
  • 呼吸电刺激

情态

  • 固定式
  • 便携的

购买方式

  • 非处方设备
  • 基于处方的设备

疼痛类型

  • 周围神经病变
  • 卡压性神经病
  • 幻肢神经病
  • 三叉神经痛
  • 带状疱疹后神经痛 (PHN)
  • 创伤后神经病变
  • 脚痛
  • 尾骨痛

指征

  • 脊椎狭窄
  • 化疗引起的周围神经病变
  • 糖尿病神经病变
  • 其他的

最终用户

分销渠道

  • 直接招标
  • 第三方分销商
  • 其他的

欧洲神经性疼痛市场区域分析/见解

对欧洲神经性疼痛市场进行了分析，并按国家、类型、产品类型、程序、技术、方式、购买方式、疼痛类型、适应症、最终用户和分销渠道提供了市场规模洞察和趋势。

欧洲神经性疼痛市场报告涵盖的国家包括德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其和欧洲其他地区

德国在欧洲神经性疼痛市场占据主导地位，因为该地区拥有强大的医疗设施基础、主要市场参与者的强大影响力以及不断增加的研究活动。   

预计在 2023 年至 2030 年的预测期内，德国将见证欧洲神经性疼痛市场的显著增长，这得益于政府加大力度提高认识、医疗旅游业蓬勃发展、该地区研究活动日益增多、拥有大量尚未开发的市场、人口众多以及该地区对优质医疗服务的需求日益增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

欧洲神经性疼痛市场还为您提供详细的市场分析，包括每个国家资本设备医疗支出的增长、欧洲神经性疼痛市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对欧洲神经性疼痛市场的影响。数据涵盖 2015-2020 年的历史时期。

竞争格局和欧洲神经性疼痛市场份额分析

欧洲神经性疼痛市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对欧洲神经性疼痛市场的关注有关。

欧洲神经性疼痛市场的一些主要参与者包括：

  • NEVRO CORP.（美国）
  •  波士顿科学公司 (美国)
  •  雅培（美国）
  •  electroCore, Inc.（美国）
  •  Polar Medical（英国）
  •  B.Braun Melsungen AG（德国）
  •  欧姆龙医疗股份有限公司 (日本)
  •  Cirtec（美国）
  •  美敦力（爱尔兰）
  • 辉瑞公司（美国）
  •  诺华公司（瑞士）
  •  Virpax Pharmaceuticals, Inc.（美国）
  •  安进公司（美国）
  • Integer Holdings Corporation（美国）
  •  AVNS（美国） 

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Neuropathic pain MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET type of manufacturer COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. regulation
    1. REGULATORY GUIDELINES AS PER USFDA
    2. REGULATORY GUIDELINES AS PER EUROPEAN UNION
  6. market overview
    1. drivers
      1. Growing prevalence of chronic pain and neuropathic condition
      2. Increasing Cases Of Diabetic Neuropathy
      3. Increasing R&D Expenditure
      4. Advancement In New Neuromodulation Technology
      5. Penetration Of the New Market Players
    2. RESTRAINTS
      1. High cost of the medical devices
      2. Low awareness for neuropathic pain devices
      3. unfavorable government policies
      4. Limitation of Neuropathic medical Devices
    3. OPPORTUNITIES
      1. High Risk Of Neuropathic Pain With Ageing
      2. Government initiatives for neuropathic pain
      3. Appropriate Reimbursement policy for the medical devices
    4. CHALLENGES
      1. Dearth of skilled professionals
      2. Use of traditional therapy in emerging economies
  7. IMPACT OF COVID-19 ON THE EUROPE NEUROPATHIC PAIN MARKET
    1. OVERVIEW
    2. IMPACT ON PRICE
    3. IMPACT ON SUPPLY
    4. STRATEGIC DECISIONS BY MANUFACTURERS
    5. CONCLUSION-
  8. europe Neuropathic pain MARKET, BY Type
    1. overview
    2. SPINAL CORD STIMULATION (SCS) DEVICES
      1. Rechargeable Implantable Pulse Generator
      2. Radiofrequency Stimulator
      3. Conventional Implantable Pulse Generator/ IPG
    3. EXTERNAL PERIPHERAL NERVE STIMULATION
      1. Deep Brain Stimulators (DBS)
        1. Dual-Channel Deep Brain Stimulator
        2. Single-Channel Deep Brain Stimulator
      2. Transcranial Magnetic Stimulators (TMS)
      3. Vagus Nerve Stimulators (VNS)
      4. Sacral Nerve Stimulators (SNS)
    4. TRANSCUTANEOUS ELECTRIC NERVE STIMULATION (TENS) DEVICES
      1. Conventional Tens (Low-intensity, High-Frequency)
      2. Acupuncture-Like Tens (High-Intensity, Low-Frequency)
      3. Intense Tens (High-Intensity, High-Frequency)
  9. europe Neuropathic pain MARKET, BY product type
    1. overview
    2. rechargeable
    3. non- rechargeable
  10. europe Neuropathic pain MARKET, BY Procedure
    1. overview
    2. Non-Invasive
    3. invasive
  11. europe Neuropathic pain MARKET, BY technology
    1. overview
    2. TRANSCUTANEOUS ELECTRIC NERVE STIMULATION
    3. TRANSCRANIAL MAGNETIC STIMULATION
    4. Respiratory Electrical Stimulation
  12. europe Neuropathic pain MARKET, BY Modality
    1. overview
    2. portable
      1. Rechargeable
      2. Non- Rechargeable
    3. stationary
      1. Rechargeable
      2. Non- Rechargeable
  13. europe Neuropathic pain MARKET, BY Mode of Purchase
    1. overview
    2. Prescription-Based Devices
    3. Over-The-Counter Devices
  14. europe Neuropathic pain MARKET, BY Pain Type
    1. overview
    2. Peripheral Neuropathy
    3. Phantom Limb Pain
    4. Post Herpetic Neuralgia (PHN)
    5. Post Traumatic Neuropathy
    6. Entrapment Neuropathy
    7. Foot Pain
    8. Trigeminal Neuralgia
    9. Coccydynia
    10. others
  15. europe Neuropathic pain MARKET, BY indication
    1. overview
    2. Spinal Stenosis
      1. Spinal Cord Stimulation (SCS) Devices
      2. Transcutaneous Electrical Nerve Stimulation (TENS) devices
      3. External Peripheral Nerve Stimulation
    3. Diabetic Neuropathy
      1. Spinal Cord Stimulation (SCS) Devices
      2. Transcutaneous Electrical Nerve Stimulation (TENS) devices
      3. External Peripheral Nerve Stimulation
    4. Chemotherapy-Induced Peripheral Neuropathy
      1. Spinal Cord Stimulation (SCS) Devices
      2. Transcutaneous Electrical Nerve Stimulation (TENS) devices
      3. External Peripheral Nerve Stimulation
    5. others
  16. europe Neuropathic pain MARKET, BY end user
    1. overview
    2. Clinics
    3. Hospitals
      1. Acute Care Hospitals
      2. Long-Term Care Hospitals
      3. Nursing Facilities
      4. Rehabilitation Centers
    4. Home Healthcare
    5. Ambulatory Surgical Centers
    6. others
  17. europe Neuropathic pain MARKET, BY distribution channel
    1. overview
    2. Direct Tenders
    3. Third Party Distribution
    4. others
  18. Europe neuropathic Pain market by geography
    1. Overview
    2. EUROPE
      1. GERMANY
      2. france
      3. U.K.
      4. Italy
      5. Russia
      6. Spain
      7. Netherlands
      8. Turkey
      9. Switzerland
      10. Rest of Europe
  19. Europe Neuropathic Pain Market: COMPANY landscape
    1. company share analysis: europe
  20. swot analysis
  21. Company profile
    1. medtronic
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. boston scientific corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. ABBOTT
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. nervo corp.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. omron healthcare, INC.
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. Interger holdings corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. avns
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. b.braun melsungen AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. Cirtec
      1. 257
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. ELECTROCORE, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Neurometrix, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. Polar medical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Spr therapeutics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. Stimwave LLC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. sunmed
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  22. questionnaire
  23. related reports

表格列表

TABLE 1 Europe Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 2 Europe Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 3 Europe Spinal Cord Stimulation (SCS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 4 Europe External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 5 Europe External Peripheral Nerve Stimulationin Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 6 Europe Deep Brain Stimulators (DBS) in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 7 Europe Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 8 Europe Transcutaneous Electrical Nerve Stimulation (TENS) Devices in Neuropathic Pain Market, By Type, 2019-2028 (USD Million)

TABLE 9 Europe Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)

TABLE 10 Europe Rechargeable in Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)

TABLE 11 Europe Non-Rechargeable Neuropathic Pain Market, By Product Type, 2019-2028 (USD Million)

TABLE 12 Europe Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)

TABLE 13 Europe Non-Invasive Invasive in Neuropathic Pain Device Market, By Procedure, 2019-2028 (USD Million)

TABLE 14 Europe Invasive in Neuroendocrine Tumors Market, By Classification 2019-2027 (USD Million)

TABLE 15 Europe Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 16 Europe Transcutaneous Electrical Nerve Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 17 Europe Transcranial Magnetic Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 18 Europe Respiratory Electrical Stimulation Neuropathic Pain Market, By Technology, 2019-2028 (USD Million)

TABLE 19 Europe Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 20 Europe Portable Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 21 Europe Portable in Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 22 Europe Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 23 Europe Stationary Neuropathic Pain Market, By Modality, 2019-2028 (USD Million)

TABLE 24 Europe Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)

TABLE 25 Europe Prescription-Based Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)

TABLE 26 Europe Over-The-Counter Devices Neuropathic Pain Market, By Mode of Purchase, 2019-2028 (USD Million)

TABLE 27 Europe Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 28 Europe Peripheral Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 29 Europe Phantom Limb Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 30 Europe Post Herpetic Neuralgia (PHN) Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 31 Europe Post Traumatic NeuropathyNeuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 32 Europe Entrapment Neuropathy Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 33 Europe Foot Pain Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 34 Europe Trigeminal Neuralgia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 35 Europe Coccydynia Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 36 Europe Others Neuropathic Pain Market, By Pain Type, 2019-2028 (USD Million)

TABLE 37 Europe Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 38 Europe Spinal Stenosis Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 39 Europe Spinal Stenosis in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 40 Europe Diabetic Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 41 Europe Diabetic Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 42 Europe Chemotherapy-Induced Peripheral Neuropathy Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 43 Europe Chemotherapy-Induced Peripheral Neuropathy in Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 44 Europe Others Neuropathic Pain Market, By Indication, 2019-2028 (USD Million)

TABLE 45 Europe Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 46 Europe Clinics Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 47 Europe Hospitals Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 48 Europe Hospitals in Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 49 Europe Home Healthcare Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 50 Europe Ambulatory Surgical Centers Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 51 Europe Others Neuropathic Pain Market, By End User, 2019-2028 (USD Million)

TABLE 52 Europe Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 53 Europe Direct Tenders Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 54 Europe Third Party Distribution Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 Europe Others Neuropathic Pain Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 EUROPE neuropathic Pain MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 57 Europe NEUROPATHIC PAIN MARKET, By Region, 2019-2028 (USD Million)

TABLE 58 EUROPE NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 59 EUROPE Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 60 EUROPE External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 61 EUROPE Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 62 EUROPE Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 63 EUROPE NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 64 EUROPE NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 65 EUROPE NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 66 EUROPE NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 67 EUROPE Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 68 EUROPE portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 69 EUROPE NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 70 EUROPE NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 71 EUROPE NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 72 EUROPE SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 73 EUROPE Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 74 EUROPE Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 75 EUROPE NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 76 EUROPE hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 77 EUROPE NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 78 GERMANY NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 79 GERMANY Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 80 GERMANY External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 81 germany Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 82 GERMANY Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 83 GERMANY NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 84 GERMANY NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 85 GERMANY NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 86 GERMANY NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 87 GERMANY Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 88 GERMANY portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 89 GERMANY NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 90 GERMANY NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 91 GERMANY NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 92 GERMANY SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 93 GERMANY Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 94 GERMANY Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 95 GERMANY NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 96 GERMANY hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 97 GERMANY NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 98 france NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 99 france Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 100 france External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 101 france Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 102 france Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 103 france NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 104 france NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 105 france NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 106 france NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 107 france Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 108 france portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 109 france NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 110 france NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 111 france NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 112 france SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 113 france Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 114 france Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 115 france NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 116 france hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 117 france NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 118 U.K. NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 119 U.K. Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 120 U.K. External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 121 U.K. Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 122 U.K. Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 123 U.K. NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 124 U.K. NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 125 U.K. NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 126 U.K. NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 127 U.K. Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 128 U.K. portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 129 U.K. NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 130 U.K. NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 131 U.K. NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 132 U.K. SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 133 U.K. Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 134 U.K. Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 135 U.K. NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 136 U.K. hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 137 U.K. NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 138 italy NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 139 italy Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 140 italy External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 141 italy Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 142 italy Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 143 italy NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 144 italy NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 145 italy NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 146 italy NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 147 italy Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 148 italy portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 149 italy NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 150 italy NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 151 italy NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 152 italy SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 153 italy Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 154 italy Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 155 italy NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 156 italy hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 157 italy NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 158 russia NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 159 russia Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 160 russia External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 161 russia Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 162 russia Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 163 russia NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 164 russia NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 165 russia NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 166 russia NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 167 russia Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 168 russia portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 169 russia NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 170 russia NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 171 russia NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 172 russia SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 173 russia Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 174 russia Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 175 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 176 russia hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 177 russia NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 178 spain NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 179 spain Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 180 spain External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 181 spain Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 182 spain Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 183 spain NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 184 spain NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 185 spain NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 186 spain NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 187 spain Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 188 spain portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 189 spain NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 190 spain NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 191 spain NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 192 spain SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 193 spain Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 194 spain Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 195 russia NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 196 spain hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 197 spain NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 198 Netherlands NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 199 Netherlands Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 200 Netherlands External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 201 Netherlands Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 202 Netherlands Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 203 Netherlands NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 204 Netherlands NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 205 Netherlands NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 206 Netherlands NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 207 Netherlands Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 208 Netherlands portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 209 Netherlands NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 210 Netherlands NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 211 Netherlands NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 212 Netherlands SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 213 Netherlands Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 214 Netherlands Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 215 Netherlands NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 216 Netherlands hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 217 Netherlands NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 218 turkey NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 219 turkey Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 220 turkey External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 221 turkey Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 222 turkey Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 223 turkey NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 224 turkey NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 225 turkey NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 226 turkey NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 227 turkey Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 228 turkey portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 229 turkey NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 230 turkey NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 231 turkey NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 232 turkey SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 233 turkey Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 234 turkey Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 235 turkey NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 236 turkey hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 237 turkey NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 238 Switzerland NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 239 Switzerland Spinal Cord Stimulation (SCS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 240 Switzerland External Peripheral Nerve Stimulation in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 241 Switzerland Deep Brain Stimulators (DBS) in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 242 Switzerland Transcutaneous Electrical Nerve Stimulation (TENS) Devices in NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

TABLE 243 Switzerland NEUROPATHIC PAIN MARKET, By PRODUCT TYPE, 2019-2028 (USD Million)

TABLE 244 Switzerland NEUROPATHIC PAIN MARKET, By PROcedure, 2019-2028 (USD Million)

TABLE 245 Switzerland NEUROPATHIC PAIN MARKET, By technology, 2019-2028 (USD Million)

TABLE 246 Switzerland NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 247 Switzerland Stationary in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 248 Switzerland portable in NEUROPATHIC PAIN MARKET, By Modality, 2019-2028 (USD Million)

TABLE 249 Switzerland NEUROPATHIC PAIN MARKET, By Mode of purchase, 2019-2028 (USD Million)

TABLE 250 Switzerland NEUROPATHIC PAIN MARKET, By pain type, 2019-2028 (USD Million)

TABLE 251 Switzerland NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 252 Switzerland SPINAL STENOSIS IN NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 253 Switzerland Chemotherapy-Induced Peripheral Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 254 Switzerland Diabetic Neuropathy in NEUROPATHIC PAIN MARKET, By INDICATION, 2019-2028 (USD Million)

TABLE 255 Switzerland NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 256 Switzerland hospitals in NEUROPATHIC PAIN MARKET, By end user, 2019-2028 (USD Million)

TABLE 257 Switzerland NEUROPATHIC PAIN MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 258 Rest of Europe NEUROPATHIC PAIN MARKET, By type, 2019-2028 (USD Million)

图片列表

FIGURE 1 Europe NEUROPATHIC PAIN MARKET: SEGMENTATION

FIGURE 2 EUROPE NEUROPATHIC PAIN MARKET: DATA TRIANGULATION

FIGURE 3 europe Neuropathic pain Market: DROC ANALYSIS

FIGURE 4 Europe Neuropathic pain market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Neuropathic pain Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Neuropathic pain MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Neuropathic pain MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE NEUROPATHIC PAIN MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE NEUROPATHIC PAIN MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE Neuropathic pain MARKET: MARKET type COVERAGE GRID

FIGURE 11 Europe Neuropathic pain market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE EUROPE Neuropathic pain market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GROWING PREVALENCE OF CHRONIC PAIN, NEUROPATHIC CONDITION, AND INCREASING CASES OF DIABETIC NEUROPATHY IS DRIVING THE EUROPE NEUROPATHIC PAIN MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 SPINAL CORD STIMULATION (SCS) DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE NEUROPATHIC PAIN MARKET IN 2021 & 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE NEUROPATHIC PAIN MARKET

FIGURE 16 ESTIMATED CASES OF PERIPHERAL NEUROPATHY IN AMERICAN POPULATION

FIGURE 17 PREVALENCE OF NEUROPATHIC PAIN IN TYPE 1 AND TYPE 2 DIABETES

FIGURE 18 europe Neuropathic pain market: BY type, 2020

FIGURE 19 europe Neuropathic pain market: BY type, 2020-2028 (USD Million)

FIGURE 20 europe Neuropathic pain market: BY type, CAGR (2020-2028)

FIGURE 21 europe Neuropathic pain market: BY type, LIFELINE CURVE

FIGURE 22 europe Neuropathic pain market: BY product type, 2020

FIGURE 23 europe Neuropathic pain market: BY product type, 2020-2028 (USD Million)

FIGURE 24 europe Neuropathic pain market: BY product type, CAGR (2020-2028)

FIGURE 25 europe Neuropathic pain market: BY product type, LIFELINE CURVE

FIGURE 26 europe Neuropathic pain market: BY procedure, 2020

FIGURE 27 europe Neuropathic pain market: BY procedure, 2020-2028 (USD Million)

FIGURE 28 europe Neuropathic pain market: BY procedure, CAGR (2020-2028)

FIGURE 29 europe Neuropathic pain market: BY procedure, LIFELINE CURVE

FIGURE 30 europe Neuropathic pain market: BY technology, 2020

FIGURE 31 europe Neuropathic pain market: BY technology, 2020-2028 (USD Million)

FIGURE 32 europe Neuropathic pain market: BY technology, CAGR (2020-2028)

FIGURE 33 europe Neuropathic pain market: BY technology, LIFELINE CURVE

FIGURE 34 europe Neuropathic pain market: BY modality, 2020

FIGURE 35 europe Neuropathic pain market: BY modality, 2020-2028 (USD Million)

FIGURE 36 europe Neuropathic pain market: BY modality, CAGR (2020-2028)

FIGURE 37 europe Neuropathic pain market: BY modality, LIFELINE CURVE

FIGURE 38 europe Neuropathic pain market: BY mode of purchase, 2020

FIGURE 39 europe Neuropathic pain market: BY mode of purchase, 2020-2028 (USD Million)

FIGURE 40 europe Neuropathic pain market: BY mode of purchase, CAGR (2020-2028)

FIGURE 41 europe Neuropathic pain market: BY mode of purchase, LIFELINE CURVE

FIGURE 42 europe Neuropathic pain market: BY pain type, 2020

FIGURE 43 europe Neuropathic pain market: BY pain type, 2020-2028 (USD Million)

FIGURE 44 europe Neuropathic pain market: BY pain type, CAGR (2020-2028)

FIGURE 45 europe Neuropathic pain market: BY pain type, LIFELINE CURVE

FIGURE 46 europe Neuropathic pain market: BY indication, 2020

FIGURE 47 europe Neuropathic pain market: BY indication, 2020-2028 (USD Million)

FIGURE 48 europe Neuropathic pain market: BY indication, CAGR (2020-2028)

FIGURE 49 europe Neuropathic pain market: BY indication, LIFELINE CURVE

FIGURE 50 europe Neuropathic pain market: BY end user, 2020

FIGURE 51 europe Neuropathic pain market: BY end user, 2020-2028 (USD Million)

FIGURE 52 europe Neuropathic pain market: BY end user, CAGR (2020-2028)

FIGURE 53 europe Neuropathic pain market: BY end user, LIFELINE CURVE

FIGURE 54 europe Neuropathic pain market: BY distribution channel, 2020

FIGURE 55 europe Neuropathic pain market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 56 europe Neuropathic pain market: BY distribution channel, CAGR (2020-2028)

FIGURE 57 europe Neuropathic pain market: BY distribution channel, LIFELINE CURVE

FIGURE 58 EUROPE neuropathic Pain market: SNAPSHOT (2020)

FIGURE 59 EUROPE neuropathic Pain market: BY COUNTRY (2020)

FIGURE 60 EUROPE neuropathic Pain market: BY COUNTRY (2021 & 2028)

FIGURE 61 EUROPE neuropathic Pain market: BY COUNTRY (2020 & 2028)

FIGURE 62 EUROPE neuropathic Pain market: BY Product & services (2021-2028)

FIGURE 63 Europe Neuropathic Pain MARKET: SNAPSHOT (2020)

FIGURE 64 Europe Neuropathic Pain MARKET: BY COUNTRY (2020)

FIGURE 65 Europe Neuropathic Pain MARKET: BY COUNTRY (2021 & 2028)

FIGURE 66 Europe Neuropathic Pain MARKET: BY COUNTRY (2020 & 2028)

FIGURE 67 Europe Neuropathic Pain MARKET: BY product & Services (2021-2028)

FIGURE 68 Europe Neuropathic Pain market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe Neuropathic Pain Market will be worth USD 2,371.40 million by 2030.
The Europe Neuropathic Pain Market growth rate is 9.1% during the forecast period.
Increasing Prevalence of Neuropathic Pain & Advances in Medical Research are the growth drivers of the Europe Neuropathic Pain Market.
The type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end user and distribution channel are the factors on which the Europe Neuropathic Pain Market research is based.
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes & Vertex Pharmaceuticals Incorporated announced positive Phase 2 results of VX-548 in Acute and Neuropathic Pain by U.S. Food and Drug Administration are the latest developments in the Europe Neuropathic Pain Market.

浏览相关页面

Banner